CurrentRheuma
Get Weekly

Topic · page 23 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 881–920 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Lupus Sci Med

    Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol

    Trial design

  2. Clin Exp Rheumatol

    Anti-SSB antibodies promotes interleukin-6 production in monocytes through a toll-like receptor4-dependent way in systemic lupus erythematosus

    Mechanistic study

  3. Arthritis Res Ther

    The conditions that patients with systemic lupus erythematosus should fulfill before pregnancy to optimize outcomes: a large-scale multicenter cohort study from China

    Cohort study

  4. Lupus Sci Med

    Association of race and ethnicity with mortality in adults with SLE: a systematic literature review and meta-analysis

    Meta-analysis

  5. Lupus

    Rituximab intervention in management of thrombocytopenia in patients with systemic lupus erythematosus: A single centre experience

    Cohort study

  6. Lupus

    The impact of white matter brain lesions on processing speed deficits in systemic lupus erythematosus patients

    Cross-sectional study

  7. Lupus

    Hypertension is associated with global and renal damage accrual in patients with systemic lupus erythematosus. Data from the Almenara Lupus Cohort

    Cohort study

  8. Lupus

    Serum CXCL-13 levels are associated with active neurological involvement in patients with systemic lupus erythematosus

    Cross-sectional study

  9. N Engl J Med

    Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

    Randomized controlled trial

  10. Rheumatology (Oxford)

    Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)

    Cross-sectional study

  11. Lupus

    Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus

    Research article

  12. Rheumatology (Oxford)

    Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients

    Cohort study

  13. Lupus

    Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis at Cho Ray hospital, Vietnam

    Cross-sectional study

  14. Lupus Sci Med

    Lower circulating mitochondrial DNA and increased mitokines suggest significant mitochondrial dysfunction in systemic lupus erythematosus with renal involvement

    Cross-sectional study

  15. JAMA Netw Open

    Incidence and Factors Associated With Recurrent Pericarditis in Lupus

    Cohort study

  16. Ann Rheum Dis

    Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls

    Cohort study

  17. J Rheumatol

    Lived Education Experience of Young Adults With Childhood- and Adult-Onset Systemic Lupus Erythematosus: A Multicenter Canadian Qualitative Study

    Research article

  18. Ann Rheum Dis

    Risk of HPV-associated precancer and cancer in women with systemic lupus erythematosus

    Cohort study

  19. Ann Rheum Dis

    Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody development

    Diagnostic or prognostic study

  20. Semin Arthritis Rheum

    The effects of menopausal hormone therapy for the risk of systemic lupus erythematosus: A nationwide cohort study in Korea

    Cohort study

  21. Ann Rheum Dis

    LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

    Secondary analysis

  22. Rheumatology (Oxford)

    Plasma proteomics for risk prediction and identification of novel drug targets in systemic lupus erythematosus

    Cohort study

  23. Lupus Sci Med

    Medication-related hospitalisations in patients with SLE

    Cohort study

  24. Rheumatology (Oxford)

    Barriers to and facilitators of sustaining a systemic lupus erythematosus (SLE) patient decision aid in regular rheumatology outpatient care in the USA

    Research article

  25. Arthritis Rheumatol

    Outcome of Patients With Lupus Nephritis Treated With an Anti‐CD40 Monoclonal Antibody According to Kidney Biopsy Features

    Secondary analysis

  26. Lupus

    New insights into the long-term adverse effects of antimalarials in patients with systemic lupus erythematosus

    Cohort study

  27. Clin Exp Rheumatol

    Elevated integrin αvβ3 expression activates the NF-κB p65/p100 pathway and promotes inflammatory responses in systemic lupus erythematosus

    Mechanistic study

  28. Lupus Sci Med

    Metabolic profiles of cutaneous lupus have abnormalities in the nicotinamide adenine dinucleotide pathway

    Cross-sectional study

  29. Arthritis Rheumatol

    Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10‐Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission

    Cohort study

  30. Ann Rheum Dis

    Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways

    Mechanistic study

  31. Lupus Sci Med

    Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)

    Cohort study

  32. Arthritis Rheumatol

    Topical Mupirocin Treatment Reduces Interferon and Myeloid Signatures in Cutaneous Lupus Erythematous Lesions Through Targeting of Staphylococcus Species

    Randomized controlled trial

  33. Arthritis Res Ther

    Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study

    Cohort study

  34. Lupus

    Steroid-induced diabetes in lupus nephritis patients: Classic risk factors or a different type of diabetes?

    Case-control study

  35. Rheumatology (Oxford)

    Distinct genetic risk loci between biopsy-proven renal and non-renal lupus: a 10-year longitudinal cohort

    Cohort study

  36. Lupus Sci Med

    Ultrasonographic assessment of optic nerve: does it help in lupus-induced optic neuropathy?

    Cross-sectional study

  37. Lupus Sci Med

    Elevated serum neurofilament light chain levels in patients with neuropsychiatric systemic lupus erythematosus: a cross-sectional study

    Cross-sectional study

  38. Lupus Sci Med

    Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus

    Cohort study

  39. Lupus Sci Med

    Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis

    Cohort study

  40. Lupus Sci Med

    Impact of quality of life on overall work productivity impairment and activity impairment of patients with systemic lupus erythematosus: the PEONY study

    Cross-sectional study

All 1,848 Briefs in ExploreShowing Briefs 881–920 of 1,848, newest first